Valued at $434.0M at its later-stage round, Mar 2026. Nothing has traded since.
- ·Watch Apnimed: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Apnimed funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2026 | Early Stage VC | $25.0M | ▮ | ▮ |
| Sep 2025 | Debt | $35.0M | ▮ | ▮ |
| Apr 2025 | Early Stage VC | $16.5M | ▮ | ▮ |
| Dec 2022 | Later Stage VC | $79.7M | ▮ | ▮ |
| Apr 2022 | Later Stage VC | $62.5M | ▮ | ▮ |
| Mar 2021 | Early Stage VC | $25.0M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Apnimed valuation
Apnimed was valued at $434 million at its later-stage round in Mar 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Apnimed raised?
Apnimed has raised $434 million across 8 recorded rounds since 2018. The largest was a $79.7 million later-stage round in Dec 2022; the most recent was a $25 million early-stage round in Mar 2026.
Apnimed has filed 15 Form Ds with the SEC since 2018, most recently in Mar 2026 ($25 million sold to 2 investors).
How Apnimed's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Apnimed, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Apnimed
- What is Apnimed worth?
- Apnimed is valued at $434.0M as of Oct 2026. Valued at $434.0M at its later-stage round, Mar 2026. Nothing has traded since.
- How much has Apnimed raised?
- Apnimed has raised $434.3M in total funding across 8 recorded rounds.
- When did Apnimed last raise?
- Apnimed last raised in Mar 2026 (Early Stage VC), raising $25.0M.